Re: Separation from Employment and General Release Dear Chris,Diffusion Pharmaceuticals Inc. • March 24th, 2023 • Pharmaceutical preparations
This letter agreement and general release (this “Agreement”) sets forth the terms of your separation from employment with Diffusion Pharmaceuticals Inc. (together with its subsidiaries, “Diffusion” or the “Company”) effective March 1, 2023 (the “Separation Date”). References in this Agreement to “you” and “your” refer to Dr. Christopher D. Galloway, M.D.
Re: Separation from Employment and General Release Dear Raven,Employment Agreement • March 24th, 2023 • Diffusion Pharmaceuticals Inc. • Pharmaceutical preparations
This letter agreement and general release (this “Agreement”) sets forth the terms of your separation from employment with Diffusion Pharmaceuticals Inc. (together with its subsidiaries, “Diffusion” or the “Company”) effective March 1, 2023 (the “Separation Date”). References in this Agreement to “you” and “your” refer to Ms. Raven Jaeger, M.S.
